CompuGroup Medical SE & Co. KGaA
CMPVF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $1,154 | $1,188 | $1,209 | $1,165 |
| % Growth | -2.8% | -1.8% | 3.7% | – |
| Cost of Goods Sold | $189 | $981 | $840 | $840 |
| Gross Profit | $965 | $207 | $369 | $325 |
| % Margin | 83.6% | 17.4% | 30.5% | 27.9% |
| R&D Expenses | $0 | $0 | $114 | $140 |
| G&A Expenses | $25 | $28 | $33 | $34 |
| SG&A Expenses | $35 | $38 | $45 | $46 |
| Sales & Mktg Exp. | $9 | $9 | $12 | $12 |
| Other Operating Expenses | $825 | $0 | $10 | $0 |
| Operating Expenses | $859 | $1,005 | $233 | $185 |
| Operating Income | $106 | $171 | $136 | $140 |
| % Margin | 9.2% | 14.4% | 11.2% | 12% |
| Other Income/Exp. Net | -$44 | -$92 | -$21 | -$38 |
| Pre-Tax Income | $62 | $80 | $114 | $102 |
| Tax Expense | $27 | $28 | $35 | $33 |
| Net Income | $35 | $46 | $73 | $69 |
| % Margin | 3% | 3.9% | 6.1% | 5.9% |
| EPS | 0.67 | 0.97 | 1.5 | 1.5 |
| % Growth | -30.9% | -35.3% | 0% | – |
| EPS Diluted | 0.67 | 0.97 | 1.5 | 1.48 |
| Weighted Avg Shares Out | 52 | 52 | 52 | 52 |
| Weighted Avg Shares Out Dil | 52 | 52 | 52 | 53 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1 | $0 | $1 | $1 |
| Interest Expense | $38 | $26 | $13 | $10 |
| Depreciation & Amortization | $112 | $116 | $120 | $126 |
| EBITDA | $207 | $213 | $236 | $229 |
| % Margin | 17.9% | 17.9% | 19.5% | 19.7% |